Bowman Birk Inhibitors (BBI) in interception of inflammation and malignant transformation of OPMDs

Oral Oncol. 2018 Mar:78:220-221. doi: 10.1016/j.oraloncology.2018.02.005. Epub 2018 Feb 9.

Author

Dr Samapika Routray¹

Affiliation

¹ M.D.S(Oral Pathology & Microbiology), Department of Dental Surgery, All India Institute of Medical Sciences, Bhubaneswar, Odisha 751019, India. Electronic address: drroutray.samapika@gmail.com.

PMID: 29429632
DOI: 10.1016/j.oraloncology.2018.02.005

No abstract available

Publication types

Letter

MeSH terms

Cell Transformation, Neoplastic
Humans
Inflammation / drug therapy*
Trypsin Inhibitor, Bowman-Birk Soybean / therapeutic use*

Substances

Trypsin Inhibitor, Bowman-Birk Soybean